4
Changes in Ownership
Ernexa Therapeutics Inc. Filed Acc 0001493152-20-005355
CEO acquired 11,654 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wolff Allen · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-27 | Grant or award : show line 1 in the form | +1,074 | $1.48 | $1,590 | 140,642 | D |
| 2020-03-27 | Grant or award : show line 2 in the form | +10,580 | $1.48 | $15,658 | 151,222 | D |
Loading xslF345X03/ownership.xml…